Sign in
4

Changes in Ownership

Karyopharm Therapeutics Inc. Filed Acc 0001209191-20-056883

EVP, CBO, GC & Secretary sold 772 shares at $14.92 ($11,518)

From the SEC's structured data for this filing

Trades in this filing

Primiano Christopher Brett · EVP, CBO, GC & Secretary

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-11-02 Sale : show line 1 in the form −772 $14.92 $11,518 4,523 D
Open-market sales · 772 sh · avg $14.92 · $11,518
Loading xslF345X03/doc4.xml…